EPINEPHRINE HYDROCHLORIDE

EPINEPHRINE HYDROCHLORIDE was reported 474 times

EPINEPHRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED FACTOR V DEFICIENCY 29 0.2636
1 COAGULATION FACTOR V LEVEL ABNORMAL 19 0.1545
2 COAGULATION FACTOR DEFICIENCY 22 0.1366
3 ANTERIOR CAPSULAR RUPTURE 1 0.1250
4 ANTIMICROBIAL SUSCEPTIBILITY TEST 1 0.1111
5 STEROID DEPENDENCE 77 0.0877
6 CATARRH 77 0.0852
7 FACTOR V LEIDEN MUTATION 20 0.0504
8 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 43 0.0464
9 BURNS SECOND DEGREE 79 0.0450
10 COLD BURN 1 0.0357
11 MYOCARDIAL CALCIFICATION 4 0.0342
12 ALCOHOL POISONING 69 0.0257
13 ANAESTHETIC COMPLICATION PULMONARY 2 0.0225
14 HYPOPNOEA 77 0.0222
15 VITAMIN B1 INCREASED 1 0.0213
16 HYPERDYNAMIC LEFT VENTRICLE 5 0.0203
17 DENTAL RESTORATION FAILURE 12 0.0166
18 BURKHOLDERIA TEST POSITIVE 2 0.0161
19 ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION 1 0.0154
20 ORAL MUCOSA HAEMATOMA 1 0.0137
21 SERRATIA BACTERAEMIA 2 0.0135
22 BRONCHIECTASIS 77 0.0114
23 MEAN PLATELET VOLUME DECREASED 9 0.0107
24 ABDOMINAL LYMPHADENOPATHY 9 0.0104
25 PAROSMIA 77 0.0102
26 ANAL POLYP 1 0.0097
27 GINGIVAL PAIN 77 0.0097
28 RHINITIS 78 0.0097
29 FUNDOSCOPY ABNORMAL 1 0.0096
30 ANAL EROSION 1 0.0091
31 CARDIAC MURMUR 78 0.0090
32 NASAL DISCHARGE DISCOLOURATION 12 0.0087
33 ABDOMINAL WALL CYST 1 0.0082
34 MONOCYTE COUNT DECREASED 9 0.0074
35 PCO2 DECREASED 7 0.0072
36 MULTIPLE ALLERGIES 46 0.0059
37 CARDIAC OUTPUT INCREASED 1 0.0058
38 BLOOD LACTIC ACID DECREASED 1 0.0058
39 NASOPHARYNGEAL DISORDER 1 0.0058
40 LARYNGEAL OBSTRUCTION 1 0.0055
41 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 9 0.0054
42 CEREBELLAR ISCHAEMIA 1 0.0054
43 CORNEAL REFLEX DECREASED 2 0.0053
44 JAW CLICKING 1 0.0047
45 CATHETER SITE PAIN 12 0.0046
46 CHRONIC SPONTANEOUS URTICARIA 5 0.0043
47 IMPAIRED QUALITY OF LIFE 62 0.0043
48 CEREBRAL HYPOPERFUSION 2 0.0043
49 TUBULOINTERSTITIAL NEPHRITIS 77 0.0041
50 VAGUS NERVE DISORDER 1 0.0040
51 VITAMIN B1 DECREASED 1 0.0040
52 PO2 INCREASED 2 0.0039
53 OXYGEN SATURATION 1 0.0038
54 RETINOGRAM ABNORMAL 1 0.0037
55 NORMAL NEWBORN 20 0.0037
56 VASOPLEGIA SYNDROME 6 0.0037
57 LYMPHOCYTIC HYPOPHYSITIS 1 0.0036
58 CARBUNCLE 1 0.0035
59 IMPAIRED WORK ABILITY 74 0.0035
60 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
61 EPIGASTRIC DISCOMFORT 12 0.0031
62 FREQUENT BOWEL MOVEMENTS 78 0.0029
63 INTERVERTEBRAL DISC COMPRESSION 3 0.0029
64 LIVE BIRTH 24 0.0029
65 MAST CELL ACTIVATION SYNDROME 4 0.0028
66 ATRIAL FLUTTER 22 0.0028
67 TOXIC ANTERIOR SEGMENT SYNDROME 3 0.0027
68 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 127 0.0026
69 COAGULATION TEST ABNORMAL 2 0.0026
70 AORTIC RUPTURE 1 0.0026
71 LARYNGEAL PAIN 1 0.0025
72 SWOLLEN TONGUE 77 0.0025
73 PHLEBITIS 12 0.0023
74 CONGENITAL ANOMALY 18 0.0023
75 SYSTEMIC LUPUS ERYTHEMATOSUS 79 0.0022
76 NIGHTMARE 77 0.0022
77 LIQUID PRODUCT PHYSICAL ISSUE 16 0.0022
78 PRODUCT APPEARANCE CONFUSION 2 0.0022
79 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
80 ACCIDENTAL OVERDOSE 79 0.0022
81 OBSTRUCTIVE AIRWAYS DISORDER 24 0.0022
82 DISSEMINATED ASPERGILLOSIS 1 0.0021
83 FULL BLOOD COUNT ABNORMAL 22 0.0021
84 ROOT CANAL INFECTION 1 0.0020
85 SPLENIC HAEMORRHAGE 1 0.0020
86 ANTICHOLINERGIC SYNDROME 3 0.0019
87 COLITIS ULCERATIVE 81 0.0018
88 RECTAL HAEMORRHAGE 77 0.0018
89 ENCEPHALOMALACIA 1 0.0018
90 KOUNIS SYNDROME 4 0.0018
91 BLOOD PH DECREASED 3 0.0018
92 ENCEPHALITIS 12 0.0017
93 TINNITUS 76 0.0017
94 HYPERAESTHESIA 13 0.0016
95 NECROTISING RETINITIS 1 0.0016
96 ECZEMA 78 0.0015
97 VITREOUS HAEMORRHAGE 4 0.0014
98 DERMATITIS DIAPER 1 0.0014
99 HAEMATOCHEZIA 78 0.0014
100 TONIC CONVULSION 2 0.0014
101 RESPIRATORY TRACT CONGESTION 22 0.0014
102 PREMATURE DELIVERY 22 0.0014
103 OSMOTIC DEMYELINATION SYNDROME 1 0.0014
104 BLOOD LACTIC ACID INCREASED 7 0.0013
105 MEDICATION ERROR 73 0.0013
106 TRACHEOBRONCHITIS 1 0.0013
107 MYELITIS 2 0.0013
108 VERTIGO 78 0.0013
109 UTERINE LEIOMYOMA 9 0.0012
110 PSEUDOMONAS TEST POSITIVE 1 0.0012
111 BRADYARRHYTHMIA 2 0.0012
112 DEEP VEIN THROMBOSIS 79 0.0012
113 POOR VENOUS ACCESS 12 0.0012
114 ARTHRITIS 91 0.0012
115 CARDIAC OUTPUT DECREASED 1 0.0011
116 SINUS DISORDER 22 0.0011
117 OVARIAN DISORDER 1 0.0011
118 OXYGEN SATURATION ABNORMAL 3 0.0011
119 BLOOD BICARBONATE DECREASED 2 0.0011
120 FOREIGN BODY IN EYE 1 0.0010
121 DYSGEUSIA 76 0.0010
122 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
123 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
124 BUTTERFLY RASH 1 0.0010
125 CONJUNCTIVAL OEDEMA 1 0.0010
126 SOMATIC SYMPTOM DISORDER 1 0.0009
127 PNEUMONIA STREPTOCOCCAL 1 0.0009
128 PRODUCT SELECTION ERROR 1 0.0009
129 AORTIC DILATATION 1 0.0009
130 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 46 0.0009
131 INTENTIONAL PRODUCT USE ISSUE 77 0.0009
132 NEUTROPHIL COUNT INCREASED 9 0.0009
133 AORTIC THROMBOSIS 1 0.0009
134 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
135 HYPERTENSIVE EMERGENCY 1 0.0008
136 RESPIRATORY TRACT INFECTION 22 0.0008
137 PLATELET COUNT INCREASED 11 0.0008
138 MIGRAINE 80 0.0008
139 PULMONARY EMBOLISM 79 0.0008
140 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
141 TACHYARRHYTHMIA 2 0.0008
142 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
143 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 56 0.0008
144 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
145 SUBCUTANEOUS HAEMATOMA 1 0.0008
146 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
147 COMPARTMENT SYNDROME 2 0.0008
148 ULCER 12 0.0008
149 AREFLEXIA 2 0.0007
150 BRADYPNOEA 2 0.0007
151 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
152 ECHOCARDIOGRAM ABNORMAL 1 0.0007
153 ENDOTRACHEAL INTUBATION 2 0.0007
154 BRASH SYNDROME 1 0.0007
155 AUDITORY DISORDER 1 0.0007
156 UTERINE HAEMORRHAGE 3 0.0007
157 POST HERPETIC NEURALGIA 1 0.0007
158 PALPITATIONS 81 0.0007
159 ADVERSE DRUG REACTION 62 0.0007
160 PELVIC INFLAMMATORY DISEASE 1 0.0007
161 ASTHMA 75 0.0007
162 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
163 BLOOD PRESSURE IMMEASURABLE 1 0.0007
164 FIBROSIS 2 0.0006
165 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
166 MIDDLE INSOMNIA 12 0.0006
167 DYSPNOEA EXERTIONAL 24 0.0006
168 RESPIRATORY RATE DECREASED 2 0.0006
169 FUNGAEMIA 1 0.0006
170 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
171 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
172 PORTAL VEIN THROMBOSIS 2 0.0006
173 ARTHROPOD STING 1 0.0006
174 TROPONIN I INCREASED 1 0.0006
175 BILIARY DYSKINESIA 1 0.0006
176 DEAFNESS BILATERAL 1 0.0006
177 GAZE PALSY 1 0.0006
178 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
179 PNEUMOMEDIASTINUM 1 0.0006
180 CONTRAST MEDIA ALLERGY 1 0.0005
181 BODY TEMPERATURE ABNORMAL 1 0.0005
182 PUPILLARY REFLEX IMPAIRED 1 0.0005
183 ADRENAL DISORDER 1 0.0005
184 HAEMOLYSIS 4 0.0005
185 OCULAR HYPERTENSION 1 0.0005
186 RHINOVIRUS INFECTION 2 0.0005
187 VENOUS THROMBOSIS 2 0.0005
188 LYMPHOCYTE COUNT DECREASED 9 0.0005
189 RESPIRATORY ACIDOSIS 2 0.0005
190 METABOLIC ACIDOSIS 16 0.0005
191 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
192 CONFUSIONAL STATE 80 0.0005
193 FIBROMYALGIA 12 0.0005
194 LARYNGEAL OEDEMA 3 0.0005
195 ANAPHYLACTOID REACTION 2 0.0005
196 ABDOMINAL DISCOMFORT 81 0.0005
197 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
198 CEREBROVASCULAR ACCIDENT 81 0.0005
199 PHARYNGEAL ERYTHEMA 1 0.0005
200 MYDRIASIS 6 0.0005
201 EXOPHTHALMOS 1 0.0005
202 MYOPATHY 4 0.0005
203 COVID-19 81 0.0005
204 HEART RATE DECREASED 16 0.0005
205 HAEMATOCRIT DECREASED 9 0.0005
206 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
207 PRODUCT LOT NUMBER ISSUE 1 0.0005
208 CORNEAL OEDEMA 1 0.0004
209 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
210 HEPATOCELLULAR DAMAGE 1 0.0004
211 COMA 21 0.0004
212 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
213 DISLOCATION OF VERTEBRA 1 0.0004
214 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 79 0.0004
215 SHOCK 10 0.0004
216 PRODUCT PACKAGING CONFUSION 1 0.0004
217 HAEMATOLOGICAL INFECTION 1 0.0004
218 PHARYNGEAL SWELLING 4 0.0004
219 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
220 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
221 RASH PRURITIC 22 0.0004
222 VENOOCCLUSIVE LIVER DISEASE 2 0.0004
223 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
224 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
225 HYPERNATRAEMIA 2 0.0004
226 HEPATIC ENZYME ABNORMAL 2 0.0004
227 CATHETER SITE HAEMORRHAGE 1 0.0004
228 OSTEITIS 1 0.0004
229 WHEEZING 23 0.0004
230 APNOEA 3 0.0004
231 ANGIOEDEMA 17 0.0004
232 APLASTIC ANAEMIA 2 0.0004
233 SOMNOLENCE 77 0.0004
234 MIOSIS 3 0.0004
235 HYPERLACTACIDAEMIA 1 0.0004
236 HYDROCEPHALUS 2 0.0004
237 CLONUS 1 0.0004
238 DEPRESSION 82 0.0004
239 FUNGAL INFECTION 12 0.0004
240 NECK MASS 1 0.0004
241 INJECTION SITE SCAR 1 0.0004
242 ANAPHYLACTIC SHOCK 9 0.0003
243 COMA SCALE ABNORMAL 1 0.0003
244 ADENOVIRUS INFECTION 1 0.0003
245 RALES 2 0.0003
246 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
247 PULMONARY PAIN 1 0.0003
248 HEPATITIS FULMINANT 1 0.0003
249 MATERNAL EXPOSURE DURING PREGNANCY 30 0.0003
250 PANIC ATTACK 12 0.0003
251 EYE INJURY 1 0.0003
252 RED BLOOD CELL COUNT DECREASED 9 0.0003
253 EYE INFLAMMATION 3 0.0003
254 PAIN IN EXTREMITY 90 0.0003
255 BODY TEMPERATURE DECREASED 3 0.0003
256 PRODUCT USE IN UNAPPROVED INDICATION 75 0.0003
257 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
258 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
259 PEPTIC ULCER 1 0.0003
260 CONDITION AGGRAVATED 91 0.0003
261 POTENTIATING DRUG INTERACTION 1 0.0003
262 CEREBRAL HAEMATOMA 1 0.0003
263 BLINDNESS 12 0.0003
264 WEIGHT DECREASED 82 0.0003
265 SUDDEN CARDIAC DEATH 1 0.0003
266 BONE EROSION 1 0.0003
267 PYREXIA 96 0.0003
268 VENTRICULAR ARRHYTHMIA 1 0.0003
269 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
270 WOUND HAEMORRHAGE 1 0.0003
271 THROAT IRRITATION 12 0.0003
272 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
273 PREMATURE BABY 8 0.0003
274 CHEMOTHERAPY 1 0.0003
275 ATRIOVENTRICULAR BLOCK 2 0.0003
276 BLOOD PRESSURE DECREASED 17 0.0003
277 PULMONARY HAEMORRHAGE 2 0.0003
278 COVID-19 PNEUMONIA 3 0.0003
279 BACTERAEMIA 3 0.0003
280 AZOTAEMIA 1 0.0003
281 MUSCLE HAEMORRHAGE 1 0.0002
282 ORGAN FAILURE 1 0.0002
283 MYASTHENIA GRAVIS 2 0.0002
284 C-REACTIVE PROTEIN INCREASED 9 0.0002
285 RASH 107 0.0002
286 INFUSION RELATED REACTION 16 0.0002
287 GASTROINTESTINAL PERFORATION 1 0.0002
288 PNEUMONIA ASPIRATION 6 0.0002
289 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
290 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
291 HYPERPYREXIA 1 0.0002
292 CIRCULATORY COLLAPSE 4 0.0002
293 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
294 DIVERTICULUM INTESTINAL 1 0.0002
295 ILEUS PARALYTIC 1 0.0002
296 SUSPECTED OFF LABEL USE 1 0.0002
297 BLOOD CHOLESTEROL INCREASED 10 0.0002
298 PULSE ABSENT 1 0.0002
299 EYE IRRITATION 12 0.0002
300 HYPERTHYROIDISM 3 0.0002
301 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
302 EMPHYSEMA 2 0.0002
303 DRUG TOLERANCE 1 0.0002
304 DEVICE FAILURE 3 0.0002
305 PRODUCT COLOUR ISSUE 1 0.0002
306 HAEMOGLOBIN DECREASED 20 0.0002
307 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
308 SKIN NECROSIS 1 0.0002
309 PERIORBITAL OEDEMA 1 0.0002
310 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
311 HYPERTENSION 40 0.0002
312 NYSTAGMUS 1 0.0002
313 RHINORRHOEA 12 0.0002
314 ANAL ABSCESS 1 0.0002
315 BLOOD BILIRUBIN INCREASED 5 0.0002
316 HYPERSENSITIVITY 34 0.0002
317 DYSPNOEA 103 0.0002
318 INTESTINAL ISCHAEMIA 1 0.0002
319 FOOT DEFORMITY 2 0.0002
320 STREPTOCOCCAL INFECTION 1 0.0002
321 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
322 GRANULOCYTOPENIA 1 0.0002
323 HYPERTONIA 1 0.0002
324 MOUTH SWELLING 1 0.0002
325 HOT FLUSH 13 0.0002
326 METABOLIC DISORDER 1 0.0002
327 STRESS CARDIOMYOPATHY 1 0.0002
328 HYPOVOLAEMIA 1 0.0002
329 HEADACHE 107 0.0002
330 OFF LABEL USE 148 0.0002
331 BRONCHITIS 12 0.0002
332 PRODUCT QUALITY ISSUE 22 0.0002
333 DRUG DIVERSION 1 0.0002
334 THROMBOSIS 13 0.0002
335 URTICARIA 27 0.0002
336 ILEUS 2 0.0002
337 SWELLING 15 0.0002
338 INJECTION SITE DISCOLOURATION 2 0.0002
339 INFUSION SITE SWELLING 1 0.0002
340 INTRAOCULAR PRESSURE INCREASED 2 0.0002
341 SEROTONIN SYNDROME 3 0.0002
342 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
343 PAIN 95 0.0002
344 BREAST CANCER STAGE III 1 0.0002
345 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
346 PRODUCT PREPARATION ISSUE 1 0.0002
347 ASPERGILLUS INFECTION 1 0.0002
348 SOMNAMBULISM 1 0.0002
349 HYPOGAMMAGLOBULINAEMIA 1 0.0002
350 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
351 BLOOD PRESSURE ABNORMAL 3 0.0002
352 SYNCOPE 15 0.0001
353 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
354 CHOLECYSTITIS CHRONIC 1 0.0001
355 INJURY ASSOCIATED WITH DEVICE 3 0.0001
356 TACHYPNOEA 2 0.0001
357 ABNORMAL LOSS OF WEIGHT 1 0.0001
358 INFARCTION 1 0.0001
359 CARDIAC ARREST 12 0.0001
360 LARGE INTESTINE POLYP 1 0.0001
361 HYPOMAGNESAEMIA 2 0.0001
362 APHONIA 2 0.0001
363 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
364 SEASONAL ALLERGY 2 0.0001
365 DIVERTICULUM 1 0.0001
366 ANXIETY 40 0.0001
367 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
368 CARDIOGENIC SHOCK 2 0.0001
369 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
370 SKIN HAEMORRHAGE 2 0.0001
371 HEPATIC FAILURE 4 0.0001
372 DYSPEPSIA 13 0.0001
373 HAEMODYNAMIC INSTABILITY 1 0.0001
374 ACIDOSIS 1 0.0001
375 FOOD ALLERGY 1 0.0001
376 EJECTION FRACTION DECREASED 2 0.0001
377 TORSADE DE POINTES 1 0.0001
378 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
379 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
380 AFFECTIVE DISORDER 1 0.0001
381 CYANOSIS 2 0.0001
382 FURUNCLE 1 0.0001
383 LOW BIRTH WEIGHT BABY 1 0.0001
384 RESPIRATORY FAILURE 9 0.0001
385 BLOOD POTASSIUM INCREASED 2 0.0001
386 SHOCK HAEMORRHAGIC 1 0.0001
387 HICCUPS 1 0.0001
388 DRUG LEVEL INCREASED 2 0.0001
389 MENSTRUAL DISORDER 1 0.0001
390 COAGULOPATHY 2 0.0001
391 RHABDOMYOLYSIS 5 0.0001
392 DRY SKIN 16 0.0001
393 CHILLS 14 0.0001
394 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
395 FATIGUE 92 0.0001
396 SINUSITIS 12 0.0001
397 PRODUCT CONTAINER ISSUE 1 0.0001
398 UNRESPONSIVE TO STIMULI 3 0.0001
399 DRUG INEFFECTIVE 153 0.0001
400 DEVICE DEFECTIVE 2 0.0001
401 SEPTIC SHOCK 5 0.0001
402 TUMOUR LYSIS SYNDROME 1 0.0001
403 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
404 RESPIRATORY RATE INCREASED 1 0.0001
405 EXPOSURE DURING PREGNANCY 7 0.0001
406 TACHYCARDIA 10 0.0001
407 CARDIOTOXICITY 1 0.0001
408 HAEMARTHROSIS 1 0.0001
409 JAUNDICE 3 0.0001
410 PALLOR 3 0.0001
411 EXOSTOSIS 1 0.0001
412 RETINAL DETACHMENT 1 0.0001
413 HYPOKALAEMIA 5 0.0001
414 HEPATIC STEATOSIS 2 0.0001
415 HEPATIC ENCEPHALOPATHY 1 0.0001
416 ERYTHEMA 22 0.0001
417 PRURITUS 41 0.0001
418 MUSCULAR WEAKNESS 12 0.0001
419 BLOOD URINE PRESENT 2 0.0001
420 PULMONARY FIBROSIS 2 0.0001
421 POST PROCEDURAL COMPLICATION 2 0.0001
422 GLAUCOMA 2 0.0001
423 PRESCRIBED OVERDOSE 2 0.0001
424 NEEDLE ISSUE 3 0.0001
425 AUTOIMMUNE DISORDER 1 0.0001
426 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
427 ASCITES 3 0.0001
428 COELIAC DISEASE 1 0.0001
429 VITREOUS FLOATERS 1 0.0001
430 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
431 PERITONITIS BACTERIAL 1 0.0001
432 FEEDING DISORDER 2 0.0001
433 TOOTH ABSCESS 1 0.0001
434 EPILEPSY 3 0.0001
435 BODY TEMPERATURE INCREASED 2 0.0001
436 TEMPERATURE INTOLERANCE 1 0.0001
437 HEREDITARY ANGIOEDEMA 1 0.0001
438 COUGH 26 0.0001
439 LACTIC ACIDOSIS 3 0.0001
440 PHARYNGITIS STREPTOCOCCAL 1 0.0001
441 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
442 VENTRICULAR FIBRILLATION 1 0.0001
443 STEVENS-JOHNSON SYNDROME 2 0.0001
444 THERAPY NON-RESPONDER 4 0.0001
445 OXYGEN SATURATION DECREASED 5 0.0001
446 TOXICITY TO VARIOUS AGENTS 15 0.0001
447 REBOUND EFFECT 1 0.0001
448 MYOCARDIAL ISCHAEMIA 1 0.0001
449 CHOLECYSTECTOMY 1 0.0001
450 MYOCARDITIS 1 0.0001
451 HYPOAESTHESIA 13 0.0001
452 PERICARDIAL EFFUSION 2 0.0001
453 CAESAREAN SECTION 1 0.0001
454 TREMOR 14 0.0001
455 HYPERLIPIDAEMIA 1 0.0001
456 BLOOD PRESSURE FLUCTUATION 2 0.0001
457 BURSITIS 1 0.0001
458 SMALL INTESTINAL OBSTRUCTION 1 0.0001
459 HEART RATE INCREASED 8 0.0001
460 HEPATIC FUNCTION ABNORMAL 3 0.0001
461 LEUKOPENIA 4 0.0001
462 MALAISE 35 0.0001
463 POISONING 1 0.0001
464 BRAIN OEDEMA 1 0.0001
465 MUCOSAL INFLAMMATION 2 0.0001
466 NASOPHARYNGITIS 14 0.0001
467 DRUG INTERACTION 12 0.0001
468 QUALITY OF LIFE DECREASED 1 0.0001
469 OEDEMA 4 0.0001
470 GINGIVAL BLEEDING 1 0.0001
471 PERIPHERAL COLDNESS 1 0.0001
472 RESPIRATORY DISTRESS 2 0.0001
473 ANAPHYLACTIC REACTION 4 0.0001
474 DIVERTICULITIS 2 0.0001
475 FEELING COLD 2 0.0001
476 SINUS TACHYCARDIA 1 0.0001
477 BRONCHOSPASM 1 0.0001
478 INJECTION SITE HAEMATOMA 1 0.0001
479 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
480 ABDOMINAL PAIN 16 0.0001
481 ABDOMINAL PAIN UPPER 14 0.0001
482 PULMONARY OEDEMA 3 0.0001
483 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
484 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
485 PHARYNGEAL OEDEMA 1 0.0001
486 DEVICE RELATED INFECTION 1 0.0001
487 MUSCULOSKELETAL CHEST PAIN 1 0.0001
488 ARRHYTHMIA 3 0.0001
489 BLOOD GLUCOSE DECREASED 3 0.0001
490 INTENTIONAL OVERDOSE 4 0.0001
491 SENSORY DISTURBANCE 1 0.0001
492 CHOLELITHIASIS 2 0.0001
493 VISUAL ACUITY REDUCED 2 0.0001
494 CYTOMEGALOVIRUS INFECTION 1 0.0001
495 LIP SWELLING 2 0.0001
496 BLOOD UREA INCREASED 1 0.0001
497 FACE OEDEMA 1 0.0001
498 HEMIPARESIS 1 0.0001
499 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
500 PNEUMONIA 19 0.0001
501 INJECTION SITE PAIN 18 0.0001
502 CHEST DISCOMFORT 6 0.0001
503 ORTHOSTATIC HYPOTENSION 1 0.0001
504 HYPOXIA 2 0.0001
505 HEAD DISCOMFORT 1 0.0001
506 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
507 MYELOSUPPRESSION 2 0.0001
508 OSTEOMYELITIS 1 0.0001
509 HYPOTENSION 11 0.0001
510 CONJUNCTIVITIS 1 0.0001
511 HYPONATRAEMIA 3 0.0001
512 HYPOCALCAEMIA 1 0.0001
513 GASTRIC ULCER 1 0.0001
514 MUSCULOSKELETAL DISORDER 1 0.0001
515 FEELING JITTERY 1 0.0001
516 SLEEP APNOEA SYNDROME 1 0.0001
517 BACK PAIN 12 0.0001
518 ORAL HERPES 1 0.0001
519 ASTHENIA 19 0.0001
520 SUICIDE ATTEMPT 3 0.0000
521 ILL-DEFINED DISORDER 3 0.0000
522 NEUTROPHIL COUNT DECREASED 2 0.0000
523 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
524 RIB FRACTURE 1 0.0000
525 PERITONITIS 1 0.0000
526 PULMONARY HYPERTENSION 1 0.0000
527 RENAL FAILURE ACUTE 2 0.0000
528 EATING DISORDER 1 0.0000
529 LOSS OF CONSCIOUSNESS 6 0.0000
530 VOMITING 22 0.0000
531 IRRITABLE BOWEL SYNDROME 1 0.0000
532 POOR QUALITY SLEEP 1 0.0000
533 PRODUCT DISPENSING ERROR 1 0.0000
534 MELAENA 1 0.0000
535 LIVER DISORDER 2 0.0000
536 HEPATOTOXICITY 1 0.0000
537 HEART RATE IRREGULAR 1 0.0000
538 SEIZURE 5 0.0000
539 PRODUCTIVE COUGH 2 0.0000
540 OVERDOSE 9 0.0000
541 PRESYNCOPE 1 0.0000
542 LUNG DISORDER 2 0.0000
543 ENCEPHALOPATHY 1 0.0000
544 HYPOPHAGIA 1 0.0000
545 HEPATITIS 1 0.0000
546 FALL 13 0.0000
547 INFLAMMATION 2 0.0000
548 RASH GENERALISED 1 0.0000
549 HAEMATOMA 1 0.0000
550 ABDOMINAL DISTENSION 4 0.0000
551 PANCREATITIS 2 0.0000
552 EAR INFECTION 1 0.0000
553 PLATELET COUNT DECREASED 4 0.0000
554 FEAR 1 0.0000
555 SKIN LESION 1 0.0000
556 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
557 RESPIRATORY ARREST 1 0.0000
558 ARTHRALGIA 15 0.0000
559 MENTAL STATUS CHANGES 1 0.0000
560 ARTHROPATHY 2 0.0000
561 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
562 HAEMOPTYSIS 1 0.0000
563 PANCYTOPENIA 2 0.0000
564 RENAL IMPAIRMENT 3 0.0000
565 EYE PAIN 2 0.0000
566 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
567 HYPERSOMNIA 1 0.0000
568 LIVER FUNCTION TEST ABNORMAL 1 0.0000
569 DYSSTASIA 1 0.0000
570 DYSPHONIA 2 0.0000
571 ACUTE MYOCARDIAL INFARCTION 1 0.0000
572 CATARACT 2 0.0000
573 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
574 CORONARY ARTERY DISEASE 1 0.0000
575 STOMATITIS 2 0.0000
576 PLEURAL EFFUSION 2 0.0000
577 NAUSEA 26 0.0000
578 DISCOMFORT 2 0.0000
579 EMOTIONAL DISORDER 1 0.0000
580 MOOD SWINGS 1 0.0000
581 CONTUSION 3 0.0000
582 NIGHT SWEATS 1 0.0000
583 AMNESIA 2 0.0000
584 SWELLING FACE 2 0.0000
585 STAPHYLOCOCCAL INFECTION 1 0.0000
586 FEBRILE NEUTROPENIA 2 0.0000
587 RENAL FAILURE 4 0.0000
588 SKIN DISORDER 1 0.0000
589 URINARY RETENTION 1 0.0000
590 GAIT INABILITY 1 0.0000
591 HEPATIC ENZYME INCREASED 2 0.0000
592 DELIRIUM 1 0.0000
593 HYPERKALAEMIA 1 0.0000
594 INJURY 2 0.0000
595 INJECTION SITE MASS 1 0.0000
596 COLITIS 1 0.0000
597 DIARRHOEA 17 0.0000
598 ANAEMIA 5 0.0000
599 BLOOD PRESSURE INCREASED 4 0.0000
600 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
601 PARAESTHESIA 4 0.0000
602 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
603 TREATMENT FAILURE 2 0.0000
604 CARDIO-RESPIRATORY ARREST 1 0.0000
605 WITHDRAWAL SYNDROME 1 0.0000
606 OSTEOARTHRITIS 1 0.0000
607 BALANCE DISORDER 2 0.0000
608 CONSTIPATION 5 0.0000
609 INTENTIONAL PRODUCT MISUSE 2 0.0000
610 MUSCULOSKELETAL STIFFNESS 2 0.0000
611 DEHYDRATION 3 0.0000
612 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
613 DEVICE ISSUE 2 0.0000
614 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
615 SKIN DISCOLOURATION 1 0.0000
616 ADVERSE EVENT 2 0.0000
617 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
618 CARDIAC DISORDER 2 0.0000
619 NEUROPATHY PERIPHERAL 2 0.0000
620 HYPOGLYCAEMIA 1 0.0000
621 CELLULITIS 1 0.0000
622 FLUID RETENTION 1 0.0000
623 ACUTE KIDNEY INJURY 3 0.0000
624 HAEMORRHAGE 2 0.0000
625 BRADYCARDIA 1 0.0000
626 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
627 INFLUENZA 2 0.0000
628 SEPSIS 2 0.0000
629 NECK PAIN 1 0.0000
630 THROMBOCYTOPENIA 2 0.0000
631 BLISTER 1 0.0000
632 FLATULENCE 1 0.0000
633 CONVULSION 1 0.0000
634 HERPES ZOSTER 1 0.0000
635 LETHARGY 1 0.0000
636 SURGERY 1 0.0000
637 PRODUCT DOSE OMISSION ISSUE 5 0.0000
638 THERAPEUTIC RESPONSE DECREASED 1 0.0000
639 OEDEMA PERIPHERAL 2 0.0000
640 FEELING HOT 1 0.0000
641 VISUAL IMPAIRMENT 2 0.0000
642 HYPERHIDROSIS 2 0.0000
643 BLOOD CREATININE INCREASED 1 0.0000
644 NEOPLASM MALIGNANT 1 0.0000
645 INJECTION SITE REACTION 1 0.0000
646 THERAPY INTERRUPTED 1 0.0000
647 MOBILITY DECREASED 1 0.0000
648 INFECTION 2 0.0000
649 AGITATION 1 0.0000
650 ACNE 1 0.0000
651 INJECTION SITE SWELLING 1 0.0000
652 DECREASED APPETITE 3 0.0000
653 INJECTION SITE BRUISING 1 0.0000
654 CARDIAC FAILURE 1 0.0000
655 CARDIAC FAILURE CONGESTIVE 1 0.0000
656 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
657 DRY MOUTH 1 0.0000
658 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
659 INFLUENZA LIKE ILLNESS 1 0.0000
660 DRUG ABUSE 1 0.0000
661 MYOCARDIAL INFARCTION 2 0.0000
662 INSOMNIA 3 0.0000
663 GASTROINTESTINAL DISORDER 1 0.0000
664 CHEST PAIN 2 0.0000
665 DRUG INTOLERANCE 1 0.0000
666 ATRIAL FIBRILLATION 1 0.0000
667 FLUSHING 1 0.0000
668 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
669 ILLNESS 1 0.0000
670 RHEUMATOID ARTHRITIS 1 0.0000
671 DISEASE PROGRESSION 1 0.0000
672 DIZZINESS 4 0.0000
673 NEUTROPENIA 1 0.0000
674 VISION BLURRED 1 0.0000
675 DRUG DEPENDENCE 1 0.0000
676 URINARY TRACT INFECTION 1 0.0000
677 MUSCLE SPASMS 1 0.0000
678 PRODUCT USE ISSUE 1 0.0000
679 ALOPECIA 1 0.0000
680 DEATH 4 0.0000
681 WEIGHT INCREASED 1 0.0000
682 INCORRECT DOSE ADMINISTERED 1 0.0000